162 related articles for article (PubMed ID: 20877132)
1. Inhibitory effect of selective cyclooxygenase-2 inhibitor lumiracoxib on human organic anion transporters hOAT1 and hOAT3.
Uwai Y; Honjo H; Iwamoto K
Drug Metab Pharmacokinet; 2010; 25(5):450-5. PubMed ID: 20877132
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of caffeic acid on human organic anion transporters hOAT1 and hOAT3: a novel candidate for food-drug interaction.
Uwai Y; Ozeki Y; Isaka T; Honjo H; Iwamoto K
Drug Metab Pharmacokinet; 2011; 26(5):486-93. PubMed ID: 21697612
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of selective cyclooxygenase-2 inhibitor etoricoxib on human organic anion transporter 3 (hOAT3).
Honjo H; Uwai Y; Iwamoto K
Drug Metab Lett; 2011 Apr; 5(2):140-37. PubMed ID: 21457143
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective inhibitory effect of flurbiprofen, ibuprofen and naproxen on human organic anion transporters hOAT1 and hOAT3.
Honjo H; Uwai Y; Aoki Y; Iwamoto K
Biopharm Drug Dispos; 2011 Dec; 32(9):518-24. PubMed ID: 22072415
[TBL] [Abstract][Full Text] [Related]
5. Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3.
Uwai Y; Honjo H; Iwamoto K
Pharmacol Res; 2012 Feb; 65(2):254-60. PubMed ID: 22108572
[TBL] [Abstract][Full Text] [Related]
6. Interaction and transport characteristics of mycophenolic acid and its glucuronide via human organic anion transporters hOAT1 and hOAT3.
Uwai Y; Motohashi H; Tsuji Y; Ueo H; Katsura T; Inui K
Biochem Pharmacol; 2007 Jun; 74(1):161-8. PubMed ID: 17462604
[TBL] [Abstract][Full Text] [Related]
7. Transport of aminopterin by human organic anion transporters hOAT1 and hOAT3: Comparison with methotrexate.
Uwai Y; Iwamoto K
Drug Metab Pharmacokinet; 2010; 25(2):163-9. PubMed ID: 20460822
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective Inhibition of Renal Basolateral Human Organic Anion Transporter 3 by Lansoprazole Enantiomers.
Hamada Y; Ikemura K; Iwamoto T; Okuda M
Pharmacology; 2018; 101(3-4):176-183. PubMed ID: 29353278
[TBL] [Abstract][Full Text] [Related]
9. Cl- -dependent upregulation of human organic anion transporters: different effects on transport kinetics between hOAT1 and hOAT3.
Ueo H; Motohashi H; Katsura T; Inui K
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F391-7. PubMed ID: 17429031
[TBL] [Abstract][Full Text] [Related]
10. Transport of the natural sweetener stevioside and its aglycone steviol by human organic anion transporter (hOAT1; SLC22A6) and hOAT3 (SLC22A8).
Srimaroeng C; Chatsudthipong V; Aslamkhan AG; Pritchard JB
J Pharmacol Exp Ther; 2005 May; 313(2):621-8. PubMed ID: 15644426
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate-loxoprofen interaction: involvement of human organic anion transporters hOAT1 and hOAT3.
Uwai Y; Taniguchi R; Motohashi H; Saito H; Okuda M; Inui K
Drug Metab Pharmacokinet; 2004 Oct; 19(5):369-74. PubMed ID: 15548848
[TBL] [Abstract][Full Text] [Related]
12. Effects of phenylpropanoids on human organic anion transporters hOAT1 and hOAT3.
Kawasaki T; Takeichi Y; Tomita M; Uwai Y; Epifano F; Fiorito S; Taddeo VA; Genovese S; Nabekura T
Biochem Biophys Res Commun; 2017 Aug; 489(4):375-380. PubMed ID: 28559139
[TBL] [Abstract][Full Text] [Related]
13. Interaction characteristics of flavonoids with human organic anion transporter 1 (hOAT1) and 3 (hOAT3).
Hong SS; Seo K; Lim SC; Han HK
Pharmacol Res; 2007 Dec; 56(6):468-73. PubMed ID: 17920288
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of pemetrexed transport by renal basolateral organic anion transporter hOAT3.
Kurata T; Iwamoto T; Kawahara Y; Okuda M
Drug Metab Pharmacokinet; 2014; 29(2):148-53. PubMed ID: 24042472
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors inhibit methotrexate transport by renal basolateral organic anion transporter hOAT3.
Chioukh R; Noel-Hudson MS; Ribes S; Fournier N; Becquemont L; Verstuyft C
Drug Metab Dispos; 2014 Dec; 42(12):2041-8. PubMed ID: 25239859
[TBL] [Abstract][Full Text] [Related]
16. Human organic anion transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) transport edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugate.
Mizuno N; Takahashi T; Iwase Y; Kusuhara H; Niwa T; Sugiyama Y
Drug Metab Dispos; 2007 Aug; 35(8):1429-34. PubMed ID: 17502342
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of the human kidney.
Wolff NA; Burckhardt BC; Burckhardt G; Oellerich M; Armstrong VW
Nephrol Dial Transplant; 2007 Sep; 22(9):2497-503. PubMed ID: 17526543
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the uptake of organic anion transporter (OAT) 1 and OAT3 substrates by human kidney slices.
Nozaki Y; Kusuhara H; Kondo T; Hasegawa M; Shiroyanagi Y; Nakazawa H; Okano T; Sugiyama Y
J Pharmacol Exp Ther; 2007 Apr; 321(1):362-9. PubMed ID: 17255469
[TBL] [Abstract][Full Text] [Related]
19. Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A).
Motohashi H; Uwai Y; Hiramoto K; Okuda M; Inui K
Eur J Pharmacol; 2004 Oct; 503(1-3):25-30. PubMed ID: 15496291
[TBL] [Abstract][Full Text] [Related]
20. The dietary polyphenol ellagic acid is a potent inhibitor of hOAT1.
Whitley AC; Sweet DH; Walle T
Drug Metab Dispos; 2005 Aug; 33(8):1097-100. PubMed ID: 15870380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
